Golvatinib Completed Phase 1 Trials for Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00869895A Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors